Fox Chase Cancer Center News

PHILADELPHIA (November 17, 2022)—It’s long been known that DNA damage caused by environmental triggers, as well as other sources of oxidative stress, contribute to the development and progression of a wide variety of cancers. Now a new study by a Fox Chase Cancer Center scientist provides new insight into how an enzyme called apurinic/apyrimidinic 1 (APE1) repairs this damage.

PHILADELPHIA (November 15, 2022)—Two Fox Chase Cancer Center researchers have received $75,000 grants from the Kidney Cancer Association (KCA) to pursue studies that could improve kidney cancer treatment and care.

PHILADELPHIA (November 15, 2022)—Four Fox Chase Cancer Center faculty have been appointed to leadership positions by fellow members of the Metropolitan Philadelphia Chapter of the American College of Surgeons (MPACS).

(PHILDELPHIA and MIAMI, November 10, 2022)— Fox Chase Cancer Center and Sylvester Comprehensive Cancer Center announced a collaboration today with Pfizer’s Institute of Translational Equitable Medicine (ITEM) to launch a cancer genomics study to characterize novel genetic, molecular, and social determinants of cancer across populations of African Ancestry.

PHILADELPHIA (November 4, 2022)—Lauren Cappelletti, BSN, RN, CCM, a transitional care nurse navigator at Fox Chase Cancer Center, was recently honored with The DAISY Award for Extraordinary Nurses as well as a visit from DAISY founders and previous award recipients.

PHILADELPHIA (October 31, 2022)—Robert Uzzo, MD, MBA, FACS, has been formally named President and CEO of Fox Chase Cancer Center following a period of interim leadership.

PHILADELPHIA (October 25, 2022)—A small subset of patients who undergo treatment for head and neck cancer may require a gastrostomy tube many years into survivorship, according to a study presented today by researchers from Fox Chase Cancer Center at the annual meeting of the American Society for Radiation Oncology.

PHILADELPHIA (October 23, 2022)—It’s common for lung cancer patients receiving radiation therapy to miss a few treatment days. But how many missed days is too many? And can providers make up for the delayed treatments by increasing the radiation dose?